The Rochester General Hospital

Rochester, NY Part of Rochester Regional Health

UEI
FJWLMDEML1Y1
CAGE
0NHY2
Primary NAICS
622110 General Medical and Surgical Hospitals
SAM.gov registration
Active through

Company facts

Self-certified in SAM.gov
  • Hospital
  • Non-Profit Organization
Entity structure
Corporate Entity (Tax Exempt)
Corporate family
SAM.gov registration date
Physical address
1425 Portland Ave, Rochester, NY 14621, USA

Registration and certifications come from SAM.gov and the SBA; company details from public web sources. Updated .

Contract awards

Grant awards

Latest 5 listed here. See the rest on GovTribe.

Grant subawards

Prime recipient Prime award Amount Awarded
Mayo Clinic Jacksonville (A Nonprofit Corporation) Optimizing the diagnostic approach to cephalosporin allergy testing (DACAT Trial) U01AI184071 $455,960
Mayo Clinic Jacksonville (A Nonprofit Corporation) Optimizing the diagnostic approach to cephalosporin allergy testing (DACAT Trial) U01AI184071 $33,243
Health Research, Inc. hospital preparedness program U3REP240747 $42,500
Health Research, Inc. Public health crisis response NU90TP922140 $1,775,656
Mayo Clinic Jacksonville (A Nonprofit Corporation) Dr. Ramsey will serve as Site Principal Investigator, overseeing the DACAT trial at RRH-AIR and will be responsible for ensuring the integrity of the clinical… U01AI184071 $385,761

Latest 5 listed here. See the rest on GovTribe.

Similar vendors

About the company

The Rochester General Hospital, a division of Rochester Regional Health, is a non-profit healthcare organization registered in SAM.gov since July 2000, specializing in medical research, clinical trials, and community healthcare services. Located in Rochester, New York, the hospital provides a range of federal government services through contract and grant awards, with a primary focus on medical research, public health initiatives, and healthcare education. The hospital is recognized for its extensive work in epidemiological research, vaccine development, infectious disease studies, and community health programs, serving as a critical partner to federal agencies in advancing medical science and public health interventions.

The Rochester General Hospital's federal contract work has been limited but focused, with a notable $1.26 million firm fixed-price contract from the Centers for Disease Control and Prevention (CDC) in fiscal year 2021. This contract supported Topic 10 of the CDC's Broad Agency Announcement, aimed at advancing epidemiological and laboratory science in the Rochester community. The contract, which ran for two years, did not have a specific set-aside designation and did not indicate major subcontractors. The hospital's contract work demonstrates its capability to execute targeted public health research and support government health initiatives through precise, mission-driven projects.

The hospital's federal grant portfolio is extensive and diverse, primarily focused on medical research and healthcare education. Significant grant awards include multiple projects from the National Institute of Allergy and Infectious Diseases (NIAID), such as vaccine development research for Haemophilus influenzae and Streptococcus pneumoniae, and studies on otitis media in children. The grants also include congressionally directed funding for community healthcare projects, construction initiatives, and nursing education support. Sub-grant awards reveal collaborative research efforts with institutions like Massachusetts General Hospital, Duke University, and the University of Rochester, covering areas such as clinical trials, hospital preparedness, COVID-19 research, and medical training. These grants, ranging from $404,539 to $1,000,000, showcase the hospital's robust research capabilities and commitment to advancing medical knowledge and community health services.

Quick answers

Is The Rochester General Hospital registered in SAM.gov?

Yes. The Rochester General Hospital's SAM.gov registration is active through January 15, 2027.

What is The Rochester General Hospital's most recent federal award?

The Rochester General Hospital's most recent federal grant award is Haemophilus influenzae lipoprotein fusion vaccine and lipoprotein vaccine platform development (R01AI187168), from National Institute of Allergy and Infectious Diseases (NIH), on November 18, 2024.

On GovTribe

See The Rochester General Hospital's full federal record

  • Federal contract awards
  • Federal grant awards
  • Subcontracting relationships
  • Funding analysis by agency, NAICS and set-aside
  • Similar vendors